House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications; create
Impact
The resolution intends to assess the conditions surrounding pharmacy benefits managers and their influence on consumer access to medications in Georgia. With rising drug costs and the potential steering of patients toward certain pharmacies, this committee will investigate the impact of PBM practices on healthcare costs and accessibility. Consequently, the outcomes of the committee's studies may lead to legislative recommendations, ultimately influencing state laws governing pharmacy benefits and consumer rights
Summary
House Resolution 948, known as HR 948, establishes the House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications. The resolution recognizes the rising costs of prescription drugs, which have exceeded inflation rates annually since 2016. It highlights the critical role pharmacy benefits managers (PBMs) play in administering drug insurance benefits and underscores the need for oversight, particularly due to allegations of unfair practices that negatively affect patients and independent pharmacies. The resolution aims to create a committee to study and address these issues comprehensively.
Sentiment
The sentiment surrounding HR 948 appears to be cautiously optimistic, particularly among healthcare advocates and legislators concerned about drug pricing and consumer access. There is a clear acknowledgment of the challenges posed by PBMs, with a shared intent to investigate and seek solutions to mitigate their negative impacts. Nevertheless, there may also be contention from certain stakeholders who could perceive this oversight as unnecessary regulation or interference in the healthcare market.
Contention
Key points of contention surrounding HR 948 include the definition and scope of the committee's powers, the balance of regulation of pharmacy benefits managers against the flexibility needed by these entities to operate effectively, and broader implications for healthcare policy in Georgia. Stakeholders will be watching closely for any proposed changes that could redefine the relationship between PBMs, pharmacies, and patients, impacting the healthcare landscape in the state.
Requesting The Administrator Of The State Health Planning And Development Agency To Convene A Pharmacy Benefit Manager Working Group To Determine The Best Policies To Reform Pharmacy Benefit Manager Practices In The State To Ensure Transparency And Fairness For Consumers And In The Pharmaceutical Sector, Lower Drug Costs For Patient Consumers, And Increase Access To Health Care.
Enacting the Kansas consumer prescription protection and accountability act and providing for regulation and registration of pharmacy benefits managers.
Enacting the Kansas consumer prescription protection and accountability act and providing for regulation and registration of pharmacy benefits managers.
Establishing the remote practice of pharmacy, requiring certain conditions for such practice and limiting activities performed under such practice, permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience, adding pharmacists who initiate such therapy to the healthcare stabilization fund and allowing a pharmacist to dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain, adopting compounding standards established by the United States pharmacopeia and allowing for exemptions from such standards and removing the authority of the state board of pharmacy to authorize individuals to access the prescription monitoring program database by rules and regulations.
Pharmacy benefit managers; permitting use of certain records without limitations of date or source for certain purposes; establishing certain reimbursement rates for certain drugs. Effective date.
Pharmacy benefit managers; permitting use of certain records without limitations of date or source for certain purposes; establishing certain reimbursement rates for certain drugs. Effective date.